Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
Abstract Background Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study w...
Saved in:
Main Authors: | Ann C. Eriksen (Author), Johnnie B. Andersen (Author), Jan Lindebjerg (Author), René dePont Christensen (Author), Torben F. Hansen (Author), Sanne Kjær-Frifeldt (Author), Flemming B. Sørensen (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer
by: Ann C. Eriksen, et al.
Published: (2017) -
Expression of Potential Dermal Progenitor Cell Markers in the Tumour and Stroma of Skin Adnexal Malignant and Benign Tumours
by: Sven R. Quist, et al.
Published: (2019) -
Metastatic Progression and Tumour Heterogeneity
Published: (2020) -
Tumour budding, MELF-pattern and tumour-infiltrating lymphocytes as possible pathomorphological parameters of the course of endometrioid adenocarcinoma of the uterine corpus
by: D. A. Zinovkin, et al.
Published: (2024) -
Alternative RNA splicing in tumour heterogeneity, plasticity and therapy
by: Sebastian Öther-Gee Pohl, et al.
Published: (2022)